Showing results (91-100 of 99) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
British Journal of Cancer|December 17, 2011
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic studyB Royer, E Kalbacher, S Onteniente, et al.British Journal of Cancer|July 20, 2000
Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2E A Rapley, R Barfoot, C Bonaïti-Pellié, et al.Kidney International|June 2, 1998
Spectrum of early onset nephrotic syndrome associated with WT1 missense mutationsV Schumacher, K Schärer, E Wühl, et al.La Revue De Medecine Interne|October 30, 2016
[Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study]E Weber, G Moulis, M Mahévas, et al.Kidney International|August 17, 2006
Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disordersK Hasselbacher, R C Wiggins, V Matejas, et al.Clinical Lymphoma, Myeloma & Leukemia|October 27, 2024
Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY CohortT Chalopin, M Macro, O Decaux, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myelomaG Fouquet, B Pegourie, M Macro, et al.Journal of Medical Genetics|August 3, 2006
STK11 status and intussusception risk in Peutz-Jeghers syndromeN Hearle, V Schumacher, F H Menko, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2025
European Myeloma Network Group review and consensus statement on primary plasma cell leukemiaP Musto, M Engelhardt, N W C J van de Donk, et al.Pageof 10